An investigational drug may only be administered to subjects under the personal supervision of the investigator or a designated subinvestigator. An investigator must not supply the drug to anyone not ...

In these cases, omissions or errors in the medication order may lead to dispensing from the wrong drug supply at the time orders are filled. Lastly, in the investigational study setting ...

Pharmaceutical companies often have a limited supply of an investigational drug, which may not be sufficient to meet the demand from both clinical trials and EAPs. 4 This raises difficult ...

Right now they’re evaluating 5 different investigational drugs for squamous cell lung cancer in the same protocol. And the plan is that over time, more investigational agents can be brought into ...

IGM Biosciences announced they are halting the development of two investigational drugs for autoimmune and inflammatory diseases, imvotamab (an IgM-based CD20 X CD3 bispecific antibody T cell engager) ...

A non-opioid investigational drug with promising pre-clinical results in treating neuropathic pain has passed an important hurdle after the study's safety review committee (SRC) reviewed the data from ...

The U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for MF-300, a first-in-class orally administered, 15-hydroxyprostaglandin ...

today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application (IND) to initiate a clinical study of the company’s investigational UKidney ...

An Investigational New Drug (IND) is a drug or biological drug that has not been approved for general use by the FDA. It is used in a clinical trial to investigate its safety and efficacy. The term ...